Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma
暂无分享,去创建一个
Shouhao Zhou | K. Young | L. Medeiros | Wei Liu | J. Westin | L. Pham | Juan Chen | R. Davis | Chan Shen | C. Ruan | Shimin Hu | R. Ford | Archito T. Tamayo | Li Li